A safety and efficacy study of autologous bone marrow cell transplantation for HIV positive patients with cirrhosis - ABMi liver regeneration project

ational Center for Global Health and Medicine0 sites10 target enrollmentMarch 2, 2011

Overview

No summary available.

Registry

who.int

Start Date

March 2, 2011

End Date

March 1, 2016

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

ational Center for Global Health and Medicine

•Cases applicable to ANY condition of the following: 1\) Hepatocellular carcinoma (HCC), except for cases having been treated completely without history of recurrence 2\) Malignant tumor other than HCC 3\) Alcoholic liver disease (ALD) 4\) Hemoglobin under 8g/dL or Platelets under 20/ml at the registration 5\) Esophageal or gastric varices with a risk of bursting, except for cases only with cured history of such conditions 6\) Cases that cannot obtain the informed consent to autologous blood transfusion 7\) Pregnancy 8\) Renal dysfunction with 2mg/dL or higher serum creatinine 9\) Performance Status 3 or 4 (assessment excludes hemophilic arthritis related daily life limitations) 10\) not fit for general anesthesia 11\) other conditions that doctor considered not suitable for the study